After surviving cancer, what about late life effects of the cure?

Julie Nonnekens; Jan H.J. Hoeijmakers

doi:10.15252/emmm.201607062

After surviving cancer, what about late life effects of the cure?

Julie Nonnekens, Jan H.J. Hoeijmakers

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

36 Citaten (Scopus)

Samenvatting

The widely used chemotherapeutic cisplatin causes ototoxicity as late‐term side effect. In this issue, Benkafadar et al (2017) decipher the mechanism of cisplatin‐induced ototoxicity and provide evidence that transient inhibition of p53 ameliorates ototoxicity without influencing chemotherapeutic efficacy. These findings may open exciting perspectives for reducing (late‐term) side effects of cancer treatment.

Originele taal-2	Engels
Pagina's (van-tot)	4-6
Aantal pagina's	3
Tijdschrift	EMBO molecular medicine
Volume	9
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.15252/emmm.201607062
Status	Gepubliceerd - 1 jan. 2017
Extern gepubliceerd	Ja

Toegang tot document

10.15252/emmm.201607062

Citeer dit

@article{d39e0d3d113f40ba8756ad89112c62c0,

title = "After surviving cancer, what about late life effects of the cure?",

abstract = "The widely used chemotherapeutic cisplatin causes ototoxicity as late‐term side effect. In this issue, Benkafadar et al (2017) decipher the mechanism of cisplatin‐induced ototoxicity and provide evidence that transient inhibition of p53 ameliorates ototoxicity without influencing chemotherapeutic efficacy. These findings may open exciting perspectives for reducing (late‐term) side effects of cancer treatment.",

author = "Julie Nonnekens and Hoeijmakers, \{Jan H.J.\}",

note = "Publisher Copyright: {\textcopyright} The Authors. Published under the terms of the CC BY 4.0 license 2016.",

year = "2017",

month = jan,

day = "1",

doi = "10.15252/emmm.201607062",

language = "English",

volume = "9",

pages = "4--6",

journal = "EMBO molecular medicine",

issn = "1757-4676",